Hansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
BUZZ-Hansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up ** Shares of Hansoh Pharmaceutical 3692.HK jump 8.3% to HK$34.38, on course for biggest one-day pct gain since August 27
** Stock hits highest level since October 8, up for a third straight session
** China's Hansoh said on Monday it had entered into a partnership and licensing deal with Roche ROPC.S potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programmes, which are targeted cancer therapies
** Under the terms of the partnership, Hansoh will lead early development until global Phase Ia clinical trials are complete. Roche will then take over worldwide development and commercialisation
** YTD, stock down 7%, while Hang Seng Biotech Index .HSBIO up 5.6%
(Reporting by Donny Kwok)
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion